CD44 and cancer: CTCs can be clustered to evade immune defense and enhance survival of cancer cells in the blood, moreover, high expression of CD44, the cancer-specific surface antigen, facilitates heterotypic adhesion of CTCs, which promises the distant metastasis of CTCs and strives for more nutrients (10, 11).